recombinant adenovirus therapy

· Momotaro-Gene Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant adenovirus therapy, covering 2020-09-04 to 2020-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer [Phase 1, Phase 2]